Skip to content

Advertisement

Molecular Brain

Research
Open Access

Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats

Molecular Brain20081:9

https://doi.org/10.1186/1756-6606-1-9

©  Zhang et al; licensee BioMed Central Ltd. 2008

Received: 26 August 2008

Accepted: 30 September 2008

Published: 30 September 2008

Abstract

Long-term potentiation (LTP) in the hippocampal CA1 region requires the activation of N-methyl-D-aspartate receptors (NMDARs). Studies using genetic and pharmacological approaches have reported inconsistent results of the requirement of NR2B-containing NMDARs in LTP in the CA1 region. Pharmacological studies showed that NR2B-containing NMDARs are not required for LTP, while genetic studies reported that over-expression of NR2B-NMDARs enhances LTP and hippocampus-dependent memory. Here, we provide evidence showing that the functional role of NR2B-NMDARs in hippocampal LTP and memory depends on LTP-inducing and behavior-conditioning protocols. Inhibition of NR2B-NMDARs with the NR2B selective antagonist ifenprodil or Ro25-6981 suppressed LTP induced by spike-timing protocol, with no impact on LTP induced by pairing protocol or two-train high-frequency stimulation (HFS) protocol. Inhibition of NR2B-NMDARs did not affect the late phase LTP induced by four-train HFS. Ca2+ imaging showed that there was difference in kinetics of intracellular Ca2+ signals induced by spiking-timing and pairing protocols. Pre-training intra-CA1 infusion of ifenprodil or Ro25-6981 impaired the contextual fear memory induced by five CS-US pairings, with no effect on the memory induced by one CS-US pairing.

Keywords

Fear MemoryIfenprodilSynaptic PotentiationContextual Fear MemoryPairing Protocol

Introduction

N-methyl-D-aspartate receptors (NMDARs) are critical for synaptic plasticity in the hippocampus and hippocampus-dependent learning and memory [1–3]. NMDAR is heteromer. Functional NMDAR has a combination of NR1 subunit and at least one of NR2 subunits (A-D). In the hippocampus, NR2A- and NR2B are two predominant NR2 subunits for NMDARs [4, 5]. The NR2-subunit compositions of NMDAR, whether they are NR2A- or NR2B-containing, determines the pharmacological and kinetic properties of the NMDAR-mediated currents [6–8]. Studies have suggested that NR2A- vs. NR2B-NMDARs may mediate distinct synaptic functions [9, 10].

Synaptic long-term potentiation (LTP) has been widely accepted as a synaptic mechanism for learning, memory and other higher-order brain functions [1, 2]. LTP can be induced in brain-slice preparations by different induction protocols [1, 11]. A recent study by Wang's group reported that NR2A- and NR2B-NMDARs may be differentially involved in synaptic plasticity in the CA1 region, with LTP being mediated by NR2A-NMDAR and LTD by NR2B-NMDAR [9]. However, the conclusion that NR2B-NMDAR is selectively involved in the induction of LTD but not LTP has been challenged by the studies using NR2A-knockout mice [12, 13] and over-expression of NR2B-NMDARs [14], suggesting the existence of NR2A-independent forms of LTP. Furthermore, it should be noted that these previous studies used different slice preparations and, especially, different protocols to induce LTP. It might be possible that NR2B-NMDARs contribute differentially to LTP induced under different conditions.

Hippocampus is an essential structure for flexible spatial memory and contextual fear memory. For example, inactivation of or lesion to the hippocampal CA1 region results in a severe deficit in contextual fear memory [15, 16]. It is well known that NMDARs in the CA1 region are involved not only in memory acquisition [3, 17, 18], but in memory retrieval as well [19]. These previous studies used non-selective NMDAR antagonists like MK-801 to access the contributions of hippocamopal NMDARs to memory acquisition and retrieval. The role of NR2B-NMDAR has been largely unclear and remains to be established.

In the present study, we examined the effects of selective blockade of NR2B-NMDARs on LTP induced by different protocols including spike-timing protocol [20, 21], paring protocol and high-frequency stimulation (HFS) protocol. We also investigated the intracellular calcium signals under different LTP-inducting protocols. We further addressed the impacts of intra-CA1 blockade of NR2B-NMDARs on the acquisition and retrieval of contextual fear memory induced by different conditioning strengths.

Materials and methods

Animals

Rats and mice were used for the present study. The animals housed in plastic cages and maintained on a 12-h light/dark cycle. Food and water were available ad libitum throughout the experiment. All experimental procedures were in accordance with the Guide for the Care and Use of Laboratory Animals issued by the National Institutes of Health, USA (1996) and approved by the Ethical Committee of Animal Experiments at Fudan University Institute of Neurobiology (Shanghai, China) and by the Animal Studies Committee at the University of Toronto (Toronto, Canada).

Drugs

To address the functions of NR2B-containing NMDARs, we used two selective antagonists: the non-competitive NR2B antagonist ifenprodil tartrate salt (Sigma-Aldrich Co., USA) and its derivative Ro25-6981 hydrochloride (Tocris, UK). In LTP recording experiments, we used the 3 μM dose of ifenprodil and the 0.3, 0.5 or 3.0 μM doses of Ro25-6981 to block NR2B-NMDARs. In behavioral experiments, we locally infused the 0.2 μg dose of ifenprodil or the 5.0 μg dose of Ro25-6981 into the CA1 region to inhibit NR2B-NMDARs.

To dissect the functions of NR2A-containing NMDARs, the relatively selective NR2A antagonist NVP-AAM077 (a generous gift from Novartis Pharma, Basel, Switzerland) was used. We selected the 0.3 μM dose of NVP-AAM077 in LTP recording experiments to dissect NR2A-NMDAR contributions, as our previous study showed that NVP-AAM077 at the dose of 0.3 μM did not affect NR2B-NMDAR currents in vitro [22]. For behavioral experiments, we locally infused the 0.012 and 0.12 μg doses of NVP-AAM077 into the CA1 region to block NR2A-NMDARs. The 0.12 μg/μl dose of NVP-AAM077 is equal to the 0.2 μg/μl dose of ifenprodil in molarity.

Whole-cell patch clamp recordings

Sprague-Dawley rats (male, 200–220 g, 8–10 week old) were used for the experiments of whole-cell patch clamp recordings. Rats were anesthetized with inhaled isoflurane. Transverse hippocampal slices (300 μm in thickness) were rapidly prepared. Slices were incubated at room temperature for at least 1 h, and were then transferred to a recording chamber. The chamber was perfused at a speed of 2 ml/min with artificial cerebrospinal fluid (ACSF) consisting of (in mM): 124 NaCl, 2.5 KCl, 2 CaCl2, 1 MgSO4, 25 NaHCO3, 1 NaH2PO4, and 10 glucose (saturated with 95% O2 and 5% CO2) and 100 μM picrotoxin. The CA3 region was removed in order to reduce transmission of picrotoxin-induced epileptiform bursting to the CA1 region. Whole-cell patch clamp recordings were made in CA1 pyramidal neurons. Targeted neurons were voltage clamped at -60 mV. EPSCs were evoked by extracellular stimulation of Schaffer collaterals using a bipolar stimulating electrode at a rate of 0.02 Hz. The stimulating electrode was placed at about 100 μm distant from the cell body.

Spike-timing and pairing protocols were used to induce LTP in patched cells. In spike-timing protocol, three presynaptic stimuli at 30 Hz, which caused three EPSPs, were paired with three postsynaptic action potentials (APs), and did so 15 times with an interval of 5 s. Presynaptic stimulus was delivered 10 ms before postsynaptic AP. The recording pipette (3–5 MΩ) was filled with solution containing (in mM): 145 K-gluconate, 5 NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 2 Mg-ATP, and 0.1 Na3-GTP (adjusted to pH 7.2 with KOH). In pairing protocol, a train of 200 stimulation pulses (at 2 Hz) were delivered presynaptically, paired with a depolarization (to -5.0 mV) of postsynaptic cell (patched cell). The recording pipette (3–5 MΩ) was filled with solution containing (in mM): 102 Cs-gluconate, 3.7 NaCl, 11 BAPTA, 0.2 EGTA, 20 HEPES, 2 Mg-ATP, 0.3 Na3-GTP and 5 QX-314 (adjusted to pH 7.2 with CsOH). After EPSC recording was stable for 10 min, spike-timing protocol or pairing protocol was used to induce LTP. The access resistance was 15–30 MΩ. The input resistance was monitored throughout the recording experiment. Data were discarded if input resistance changed by more than 20%.

Field potential recordings

C57BL/6 mice (male, 6–8 week old) were used for the experiments of field-potential recordings. Mice were anesthetized with inhaled isoflurane. Transverse slices of hippocampus were rapidly prepared and maintained in an interface chamber at 28°C, in which the slices were perfused with ACSF. The slices were kept in the recording chamber for at least 2 h before the experiments. A bipolar tungsten stimulating electrode was placed in the stratum radiatum of the CA1 region, and extracellular field potentials were recorded in the stratum radiatum, using a glass microelectrode (3–12 MΩ, filled with ACSF). Stimulation intensity was adjusted to produce a response with 0.5~1.0 mV amplitude. Test responses were elicited at 0.02 Hz. Two trains of HFS (100 pulses at 100 Hz, with inter-train interval of 20 s) were used to induce early LTP (E-LTP) and four trains of HFS (100 pulses at 100 Hz, with inter-train interval of 5 min) to induce late LTP (L-LTP).

Calcium Imaging

C57BL/6 mice (male, 3–4 week old) were used for the experiments of calcium imaging. Mice were anesthetized with inhaled isoflurane and were decapitated. Transverse slices of hippocampus (300 μm in thickness) were prepared and transferred to a submerged recovery chamber with oxygenated (95% O2 and 5% CO2) ACSF at room temperature. Oregon green BAPTA-1 (OGB-1, 0.4 mM; Molecular Probes) was dialyzed into hippocampal CA1 neurons by whole-cell patch pipettes. Once patched in whole-cell mode, the neurons were maintained for at least 10 min to allow for filling with OGB-1 before image acquisition. Fluorescent signals were imaged by a confocal microscope (Fluoview FV 1000, Olympus, Tokyo, Japan). The laser with a wavelength of 488 nm was used for excitation and fluorescence was recorded through a bandpass filter (500–550 nm). The images were acquired using a 40×, 0.8 numeric aperture water-immersion objectives every 0.5 s after a 0.188-s exposure to 488-nm light. XYT image galleries were collected. Average fluorescence intensity in the region of interests (ROI) was measured for quantification. The ROI was around 100 μm from soma. The intensity was expressed as F/F0, where F0 is the fluorescence intensity before LTP induction.

Fear conditioning

Fear conditioning was performed in a plexiglas conditioning chamber with a metal grid floor (San Diego Instruments, USA). Infrared equipment was located on the walls to monitor freezing behavior of rats. Rats were given 5 min to acclimate to the chamber pre-conditioning. Two conditioning protocols were employed. For one CS-US pairing protocol, rats were presented with one tone (conditioned stimulus, CS; 2.2 kHz and 96 dB for 30 s), which co-terminated with a foot shock (unconditioned stimulus, US; 1.0 mA, 2 s). For five CS-US pairing protocol, rats received five CS-US pairings (1.0 mA, 0.5 s for each US), with inter-pairing interval of 90–120 s [23]. After conditioning, rats were placed back to home cages.

Memory retention was tested 48 h post-conditioning. For testing of contextual fear memory, rats were placed into the original chamber, where the rats had been conditioned, and allowed to stay there for 3 min without tone or footshock. Freezing response during this period was used as a measure for contextual fear memory. For testing of auditory fear memory, rats were placed into a novel chamber for 90 s and were then given three CSs, each lasting 30 s with inter-CS interval of 20 s. Freezing response during the CS presentations was used as a measure for auditory fear memory.

Histology

To verify the locations of drug infusion, rats were anesthetized with pentobarbital sodium (50 mg/kg, i.p.) and perfused transcardially with saline, followed by 4% (vol/vol) formaldehyde solution. Rat brains were placed into 30% (wt/vol) sucrose solution and subsequently cut into 40~50 μm sections with a cryostat (Leica CM900, Germany). Brain sections were mounted on gelatin-subbed glass slides and stained with neural red (1% in ddH2O). Images were taken using a light microscope (Leica DMRXA Q5001W) equipped with a CCD camera.

Data analysis

Data in the text and figures are expressed as means± SEM. Student's t-test was used to compare LTP data. An one-way Analysis of Variance (ANOVA) was employed to compare behavioral data, with planned comparisons as post hoc analysis. In all cases, p < 0.05 was considered significant. Statistical analysis was performed using STATISTICA (StatSoft Inc., Chicago, IL, USA).

Results

LTP induced by spike-timing protocol

To test whether the involvement of NR2B-NMDARs is dependent on specific LTP induction paradigm, we first examined the role of NR2B- and NR2A-NMDARs in LTP induced by spike-timing protocol (also named EPSPs-APs protocol) (Figure 1A). To be consistent with the experimental conditions used by Wang's Group [9], we first performed whole-cell patch clamp recordings in CA1 pyramidal neurons from rat hippocampus. Spike-timing protocol caused a significant potentiation of synaptic responses (Figure 1B: 190.8 ± 12.2% of baseline at 25–30 min post-induction, n = 8 slices; p < 0.05 vs. baseline). We then tested the possible contribution of NR2B-NMDARs. The non-competitive, selective NR2B-NMDAR antagonist ifenprodil (3 μM) was perfused throughout the experiments. As shown in Figure 1C and 1E, ifenprodil significantly reduced the potentiation (121.4 ± 10.7% of baseline, n = 8 slices, p < 0.05 vs. control). Similar inhibitory effects were found with another NR2B-NMDAR antagonist Ro25-6981 (Figure 1D and 1E: For 0.3 μM Ro25-6981, 130.6 ± 13.1% of baseline, n = 7 slices, p < 0.05 vs. control; For 0.3 μM Ro25-6981, 116.1 ± 13.4% of baseline, n = 8 slices, p < 0.05 vs. control).
Figure 1
Figure 1

NR2B-NMDARs are required for LTP induced by spike-timing protocol in area CA1. A. Schematic diagram of the spike-timing protocol. B. Spike-timing protocol, as indicated by the arrow, induced a significant LTP in CA1 pyramidal neurons (n = 8). Sample traces of EPSC are the averages of 7 consecutive responses recorded during 5–10 min and 25–30 min, respectively. C. Bath application of ifenprodil partially blocked the LTP. n = 8 neurons D. Bath application of Ro25-6981 partially blocked the LTP. n = 7 neurons for 0.3 μM Ro25-6981; n = 8 neurons for 3 μM Ro25-6981. E. Histograms showing the effects of ifenprodil and Ro25-6981 on the LTP. *p < 0.05 vs. control. F. NR2A-NMDARs are required for LTP induced by spike-timing protocol in area CA1. Bath application of NVP-AAM077 blocked the LTP. n = 7 neurons. inset: Histogram showing the effect of NVP-AAM077 on the LTP. *p < 0.05 vs. control.

Bath application of the NR2A relatively selective antagonist NVP-AAM077 (0.3 μM) also reduced LTP induced by spike-timing protocol (Figure 1F: 108.9 ± 12.1% of baseline, n = 7 slices, p < 0.05 vs. control). These results provide evidence that both NR2B- and NR2A-NMDARs contribute to LTP induced by spike-timing protocol.

LTP induced by pairing protocol

Next, we examined the effect of NR2B inhibition on LTP induced by pairing protocol (Figure 2A). Whole-cell recordings were done in CA1 pyramidal cells. The pairing protocol induced a significant potentiation of synaptic responses (Figure 2B: 192.1 ± 22.0% of baseline, n = 6 slices; p < 0.05 vs. baseline). Bath application of 0.5 μM Ro25-6981 did not affect the synaptic potentiation (Figure 2C: 181.6 ± 22.8% of baseline, n = 5 slices; p < 0.05 vs. baseline). As shown in Figure 2D, there was no significant difference in LTP amplitudes in the presence and absence of Ro25-6981 (25–30 min post-induction, p > 0.05 for Ro25-6981 vs. control). This result indicates that NR2B-NMDARs are not required for LTP induced by the pairing protocol in the CA1 region, consistent with the previous report by Liu et al. [9]
Figure 2
Figure 2

NR2B-NMDARs are not required for LTP induced by pairing protocol in area CA1. A. Schematic diagram of the pairing protocol. B. Pairing protocol, as indicated by the arrow, induced a significant LTP in CA1 pyramidal neurons (n = 6). Sample traces of EPSC are the averages of 7 consecutive responses recorded during 5–10 min and 25–30 min, respectively. C. Bath application of Ro25-6981 (0.5 μM) had no effect on the LTP (n = 5). D. Histogram showing the effect of Ro25-6981 on the LTP. p > 0.05 vs. control.

LTP induced by high-frequency stimulation

We then investigated the effect of NR2B-NMDAR blockade on LTP induced by HFS using in vitro field-potential recordings. A two-train HFS induced a robust and sustained potentiation of synaptic responses in the CA1 region in control experiments (Figure 3B: 174.2 ± 22.5% of baseline at 40–45 min post-HFS, p < 0.05 vs. baseline, n = 10 slices). A similar amount of potentiation was observed in the presence of 0.5 μM Ro25-6981 (Figure 3B: 172.3 ± 15.5% of baseline, p < 0.05 vs. baseline; p > 0.05 vs. control; n = 7 slices), indicating that LTP induced by HFS does not involve NR2B-NMDARs.
Figure 3
Figure 3

NR2B-NMDARs are not required for LTP induced by HFS protocol in area CA1. A. Schematic diagram of the high frequency stimulation (HFS; 2 train). B. LTP of field EPSP induced by the HFS in control (n = 10 slices) and in the presence of Ro25-6981 (n = 7 slices). Ro25-7981 had no effect on the LTP.

To address the possible role of NR2B-NMDARs in L-LTP, we used a four-train HFS to induce L-LTP in the CA1 region (Figure 4A). As shown in Figure 5B, the potentiation of filed EPSP was robust and sustained for over 3 h after the delivery of the HFS (209.6 ± 57.0% of baseline at 170–180 min post-HFS p < 0.05 vs. baseline, n = 7 slices). Bath application of 0.5 μM Ro25-6981 did not affect the L-LTP (Figure 4B: 200.7 ± 33.5% of baseline; p < 0.05 vs. baseline; p > 0.05 vs. control, n = 5 slices). This result indicates that NR2B-NMDARs are not required for the L-LTP.
Figure 4
Figure 4

NR2B-NMDARs are not required for L-LTP induced by HFS protocol in area CA1. A. Schematic diagram of the high frequency stimulation (HFS; 4 trains). B. Late phase LTP of field EPSP induced by the HFS in control (n = 7 slices) and in the presence of Ro25-6981 (n = 5 slices). Ro25-7981 had no effect on the L-LTP.

Figure 5
Figure 5

NR2B-NMDAR mediated Ca 2+ influx under spiking-timing and pairing protocols. A. A representative image showing the CA1 pyramidal neuron filled with OGB-1. ROI, region of interests. B. Raw sample fluorescence images from the ROI before (1), during (2) and after (3) induction of LTP with the spike-timing protocol. Scale bar, 1.0 μm. C. Elevation of Ca2+ signal in the ROI during induction of LTP with the spike-timing protocol (upper). Treatment with ifenprodil (3 μM) reduced the Ca2+ signal (middle). The difference of [Ca2+] signals in control and in the presence of ifenprodil (lower) shows the NR2B-NMDAR mediated Ca2+ influx. D. Elevation of Ca2+ signal in the ROI during induction of LTP with the pairing protocol (upper). Treatment with ifenprodil (3 μM) reduced the Ca2+ signal (middle). The difference of [Ca2+] signals in control and in the presence of ifenprodil (lower) shows the NR2B-NMDAR mediated Ca2+ influx.

Ca2+ signals triggered by spike-timing and pairing protocols

Calcium influx into postsynaptic neurons is a critical event in synaptic plasticity in the CA1 region. Here, we examined the intracellular Ca2+ signals elicited by spike-timing and pairing protocols and evaluated the contributions of NR2B-NMDARs using calcium imaging. The two protocols triggered an increase in [Ca2+]i with different kinetics (Figure 5C and 5D, upper). Treatment with ifenprodil (3 μM) reduced the Ca2+ signals under both protocols (Figure 5C and 5D, middle). By calculating the difference of the signals in control and in the presence of ifenprodil, we obtained the NR2B-NMDAR mediated Ca2+ signals (Figure 5C and 5D, lower). As shown, the NR2B-NMDAR mediated calcium signal under the spike-timing protocol was much different in kinetics but not in absolute quantity from that under the pairing protocol. This difference in kinetics of Ca2+ efflux might help explain why NR2B-NMDARs are required for LTP induced by spike-timing protocol but not pairing protocol. It may be possible that the fluctuation of the NR2B-mediated Ca2+ efflux is a critical factor for induction of LTP under the spike-timing protocol.

Acquisition of contextual fear memory

A previous study in our laboratory showed that intra-CA1 blockade of NR2B-NMDARs with Ro25-6981 (5.0 μg) had no effect on the acquisition of contextual fear memory in both rats and mice [24]. In that study, we trained the animals with a single CS-US pairing. Here, we re-examined the effect of intra-CA1 blockade of NR2B-NMDARs on the acquisition of contextual fear memory using another selective NR2B-NMDAR antagonist ifenprodil. We also investigated the effect of intra-CA1 blockade of NR2A-NMDARs, using the relatively selective NR2A-NMDAR antagonist NVP-AAM077.

Intra-CA1 infusion of NVP-AAM077 (0.012 μg in 1 μl PBS, n = 6 rats; 0.12 μg in 1 μl PBS, n = 8 rats), ifenprodil (0.2 μg in 1 μl PBS, n = 7 rats), or Ro25-6981 (5.0 μg in 1 μl PBS, n = 8 rats) was performed 15 min before the animals received the single CS-US pairing protocol. PBS was similarly infused as vehicle control (1 μl; n = 9 rats). Fear memory was tested 48 h post-conditioning. As shown in Figure 6A1, rats with intra-CA1 infusion of ifenprodil demonstrated no difference in contextual freezing score in relative to vehicle controls (F(1,14) = 0.23, p > 0.05 for ifenprodil vs. vehicle). By contrary, rats with intra-CA1 infusion of NVP-AAM077 exhibited a severe deficit in contextual fear memory (F(1,13) = 7.93, p < 0.01 for 0.012 μg NVP-AAM077 vs. vehicle; F(1,15) = 6.13, p < 0.05 for 0.12 μg NVP-AAM077 vs. vehicle). Auditory fear memory was tested 1 h after contextual fear memory was tested. As shown in Figure 6A2, rats with intra-CA1 blockade of NR2B- and NR2A-NMDARs showed no deficit in auditory fear memory (F(4,31) = 0.60, p > 0.05). Thus, the acquisition of contextual fear memory induced by the single CS-US pairing involves NR2A- but not NR2B-NMDARs in the CA1 region.
Figure 6
Figure 6

NR2B-NMDARs are required for the acquisition of contextual fear memory induced by the five but not one CS-US pairing conditioning. A. Pre-training intra-CA1 inhibition of NR2B-NMDARs had no impact on, while inhibition of NR2A-NMDARs impaired 48-h contextual fear memory induced by the single CS-US pairing protocol (A1). The acquisition of auditory fear memory was intact (A2). The result with Ro25-6981 was reported in the previous study (Zhao et al., 2005). *p < 0.05 vs. vehicle B. Pre-training intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired 48-h contextual fear memory induced by the five CS-US pairing protocol (B1). The acquisition of auditory fear memory was intact (B2). **p < 0.01 vs. vehicle. C. Reconstruction of the infusion sites in the CA1 region. Filled squares: vehicle; Open circles: 0.012 μg NVP-AAM077; Filled circles: 0.12 μg NVP-AAM077; Open triangles: ifenprodil; Grey squares: Ro25-6981. D. A representative coronal section showing an infusion site of ifenprodil in the CA1 region.

Considering that the importance of NR2B-NMDARs for LTP induction is protocol-dependent, we attempted to know whether the role of NR2B-NMDARs in memory acquisition is also dependent on training paradigms. To address this, we examined the effects of intra-CA1 inhibition of NR2B- as well as NR2A-NMDARs on the acquisition of contextual fear memory induced by the five CS-US pairing conditioning. Our pilot experiment showed that the five CS-US pairing protocol could induce more freezing responses than the single CS-US pairing protocol did (Table 1).
Table 1

Contextual fear memory induced by the one and five CS-US pairing protocols

Protocol

Pre-shock

48-h Retention Test

Protocol 1: 1 CS-US (US: 1.0 mA, 2.0 s)

11.27 ± 4.65

72.86 ± 3.20

Protocol 2: 5 CS-US (US: 1.0 mA, 0.5 s)

9.53 ± 2.05

90.00 ± 1.77 **

Data is expressed as the percentage of freezing (mean ± SEM). Protocol-1: n = 7; Protocol-2: n = 6. **p < 0.01 vs. Protocol 1, t-test.

Intra-CA1 injection of NVP-AAM077 (0.012 μg in 1 μl PBS, n = 6 rats), ifenprodil (0.2 μg, n = 7 rats), or Ro25-6981 (5.0 μg, n = 8 rats) was performed 15 min before the animals was trained with the five CS-US pairing protocol. PBS was similarly infused as vehicle control (1 μl, n = 7 rats). Fear memory was tested 48 h post-conditioning. As shown in Figure 6B1, rats treated with NVP-AAM077, ifenprodil or Ro25-6981 showed a deficient contextual fear memory as compared with vehicle controls (F(1, 11) = 35.3, p < 0.01 for NVP-AAM077 vs. vehicle; F(1, 12) = 31.21, p < 0.01 for ifenprodil vs. vehicle; F(1, 13) = 26.05, p < 0.01 for Ro25-6981 vs. vehicle). However, the rats with intra-CA1 blockade of NR2B- and NR2A-NMDARs showed a normal auditory fear memory (Figure 6B2: F(3,24) = 0.72, p > 0.05). Thus, both NR2A- and NR2B-NMDARs in the CA1 region are required for the acquisition of contextual fear memory induced by the five CS-US pairing conditioning.

Retrieval of contextual fear memory

As just described, NR2B-NMDARs in the CA1 region are involved in the acquisition of contextual fear memory in a conditioning-strength dependent way. Here, we wanted to know if NR2B-NMDARs are involved in the retrieval of contextual fear memory in a similar way.

First, we examined the effects of intra-CA1 blockade of NR2B- as well as NR2A-NMDARs on memory retrieval for the single CS-US pair conditioning. NVP-AAM077 (0.012 μg in 1 μl PBS, n = 6 rats; 0.12 μg in 1 μl PBS, n = 7 rats), ifenprodil (0.2 μg in 1 μl PBS, n = 8 rats), or Ro25-6981 (5.0 μg in 1 μl PBS, n = 6 rats) was infused into the CA1 region 15 min before memory retention was tested. PBS was similarly infused as vehicle control (1 μl, n = 9 rats). As shown in Figure 7A1, An one-way ANOVA revealed a significant group effect on contextual freezing scores (F(4,31) = 8.12, p < 0.05). Planned comparison showed that the rats treated with NVP-AAM077, ifenprodil, or Ro25-6981 exhibited a deficient contextual fear memory (F(1,13) = 15.48, p < 0.01 for 0.012 μg NVP-AAM077 vs. vehicle; F(1,14) = 10.61, p < 0.01 for 0.12 μg NVP-AAM077 vs. vehicle; F(1,15) = 20.71, p < 0.01 for ifenprodil vs. vehicle; F(1, 13) = 13.23, p < 0.01 for Ro25-6981 vs. vehicle). However, each group of rats demonstrated a normal auditory fear memory (Figure 7A2: F(4, 21) = 0.62, p > 0.05).
Figure 7
Figure 7

NR2B-NMDARs are required for the retrieval of contextual fear memory induced by both five and one CS-US pairing conditioning. A. Pre-retrieval intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired the expression of 48-h contextual fear memory induced by the single CS-US pairing protocol (A1). The expression of 48-h auditory fear memory was intact (A2). **p < 0.01 vs. vehicle. B. Pre-retrieval intra-CA1 inhibition of NR2B- or NR2A-NMDARs impaired the expression of 48-h contextual fear memory induced by the five CS-US pairing protocol (B1). The expression of 48-h auditory fear memory was intact (B2). **p < 0.01 vs. vehicle. C. Reconstruction of the infusion sites in the CA1 region. Filled squares: vehicle; Filled circles: NVP-AAM077; Open triangles: ifenprodil; Open circles: Ro25-6981. D. A representative coronal section showing an infusion site of ifenprodil in the CA1 region.

Then, we examined the effects of intra-CA1 inhibition of NR2B- as well as NR2A-NMDARs on memory retrieval for the five CS-US pairing conditioning. NVP-AAM077 (0.012 μg in 1 μl PBS, n = 6 rats), ifenprodil (0.2 μg in 1 μl PBS, n = 6 rats), or Ro25-6981 (5.0 μg in 1 μl PBS, n = 5 rats) was infused into the CA1 region 15 min before memory retention test. PBS was similarly injected as vehicle control (1 μl, n = 7 rats). As shown in Figure 7B1, an one-way ANOVA revealed a significant group effect on contextual freezing scores (F(3,20) = 8.12, p < 0.01). Planned comparison showed that the rats treated with NVP-AAM077, ifenprodil, or Ro25-6981 demonstrated a deficient contextual fear memory (F(1,11) = 19.66, p < 0.01 for NVP-AAM077 vs. vehicle; F(1,11) = 12.10, p < 0.01 for ifenprodil vs. vehicle; F(1, 10) = 13.06, p < 0.01 for Ro25-6981 vs. vehicle). Auditory fear memory was intact upon the drug infusion (Figure 7B2: F(3,16) = 0.22, p > 0.05).

Taken together, these results strongly suggest that NR2B-NMDARs, as well as NR2A-NMDARs, in the CA1 region are required for the retrieval of contextual fear memory induced by the one and five CS-US pairing protocols.

Discussion

The present study shows that NR2B-NMDARs are required for LTP induced by the spike-timing protocol, but not for LTP induced by the pairing or HFS protocol. Intracellular Ca2+ signals triggered by spiking-timing and pairing protocols display different kinetics. Late-phase LTP induced by HFS protocol does not involve NR2B-NMDARs. Moreover, the significance of NR2B-NMDARs in acquisition of contextual fear memory is dependent on conditioning protocols.

Role of NR2B-NMDARs in LTP

Many previous studies using different experimental approaches have shown that NR2B-NMDARs contribute to synaptic potentiation in different areas of the central nervous system [12–14, 24–26]. However, some other studies have reported that NR2B-NMDARs are not required for synaptic potentiation or LTP [9, 10]. Considering that NR2B- and NR2A- NMDARs have different biophysical properties and couple to different intracellular signaling cascades [8, 26–29], it may be possible that different induction protocols may activate different NMDAR subtypes. Indeed, it has been reported that different LTP-inducing protocols recruit different signaling pathways. For example, in the amygdala, pairing-protocol induced LTP depends on L-type voltage-gated calcium channels (L-VGCCs) but not NMDARs, while tetanus-stimulation induced LTP involves NMDARs but not L-VGCCs [30]. In the present study, we demonstrate that the involvement of NR2B-NMDARs in LTP is dependent on induction protocols. NR2B-NMDARs are required for LTP induced by the spike-timing protocol, but not by the pairing protocol. Although it has been reported that a low dose Ro25-6981 (0.3 μM) enhances, but not reduces NMDAR-mediated EPSCs in the CA1 region [24, 31], the same dose Ro25-6981 in the present study reduced LTP induced by the spike timing protocol, but not by the pairing protocol (Table 2).
Table 2

Effects of Ro25-6981 on LTP induced by different protocols in the anterior cingulate cortex (ACC) and hippocampal CA1 region

Induction Protocol

ACC (Zhao et al., 2005)

CA1 (the present study)

Spike timing protocol

LTP blocked

LTP reduced or blocked

Pairing protocol

LTP reduced

Normal LTP

HFS protocol

--

Normal LTP

The induction of spike timing-dependent LTP requires activation of NMDAR [20, 21]. Spike timing-dependent potentiation requires the temporal window between presynaptic spikes and postsynaptic EPSPs. It is known that NR2B- and NR2A-NMDARs have different characteristics: NR2B-NMDARs have slower kinetics than NR2A-NMDARs [27]. It is possible that NR2B-NMDARs are more sensitive to the certain form of LTP induction protocol. Berberich et al. reported that the amount of charge transfer during LTP induction is a critical factor in low-frequency stimulation pairing [31]. Thus, there is such a possibility, although remains to be demosntrated, that inhibition of NR2B-NMDARs affect the charge transfer during LTP induction.

The induction-protocol dependent involvement of NR2B-NMDARs in LTP suggests that LTP induced by different protocols may have different intracellular mechanisms. Indeed, it has been suggested that different LTP induction protocols may activate distinct signaling cascades that generate LTP with different expression mechanisms [32–34]. LTP induction in the CA1 region requires Ca2+ influx through NMDAR, either through direct activation of Ca2+-sensitive substrates and/or subsequent Ca2+ release from intracellular Ca2+ stores [1, 35]. Ca2+ influx activates calcium/calmodulin-dependent protein kinase II (CaMKII), which is required as a critical cellular cascades for NMDA-dependent LTP [11, 36]. Recently, Gerkin et al. reported that NMDAR subtypes can differentially activate competitive signaling modules in the induction and integration of spike-timing-dependent plasticity [37]. That is, Ca2+ influx via NR2B-NMDARs may activate either CaMKII or calcineurin (CaN), which is dependent on the outcome of dynamic competition driven by NMDA receptor subtypes. Our data suggested that Ca2+ influx via NR2B-NMDARs induced by spike-timing protocol can activate CaMKII and lead to LTP. Furthermore, our calcium imaging in the present study showed that the NR2B-NMDAR mediated Ca2+ transients were faster under the spike-timing than pairing protocols, which might explain the different significance of NR2B-NMDARs in LTP under the two protocols since fast Ca2+ transients are better for LTP, but slow Ca2+ transients not [38].

Role of NR2B-NMDARs in memory

It has been documented that NR2B-NMDARs in the hippocampus, amygdala and anterior cingulate cortex play an important role in memory or persistent pain [14, 24, 39, 40]. Genetic over-expression of NR2B receptor subtype in the forebrain enhances spatial memory as well as contextual fear memory [14], whereas pharmacological blockade of NMDARs in the CA1 region impairs contextual fear memory [19]. Pharmacological blockade of NR2B-NMDARs in the lateral amygdala or in the ACC impairs formation of fear memory [23, 24]. However, it is unclear whether hippocampal NR2A- and NR2B-NMDARs have differential roles in fear memory formation.

The present study shows that, unlike NR2A-NMDARs that are required non-differentially, NR2B-NMDARs are involved in acquisition of contextual fear memory in a conditioning-strength dependent way. Pre-conditioning intra-CA1 infusion of the NR2B selective antagonist ifenprodil or Ro25-6981 impaired contextual fear memory induced by five but not one CS-US pairing protocol, while similar treatment with the NR2A antagonist NVP-AAM077 disrupted memory for both protocols. This is well consistent with a recent study in our laboratory [41], showing that NR2B-NMDARs in the basolateral nucleus of amygdala (BLA) are involved in acquisition of auditory fear memory also in a conditioning-strength dependent way. In that study, we reported that pre-conditioning intra-BLA infusion of the NR2B selective antagonist ifenprodil or Ro25-6981 impaired auditory fear memory induced by five but not one CS-US pairing protocol, while similar treatment with the NR2A antagonist NVP-AAM077 interfered with memory for both protocols. Consistently, genetic over-expression of NR2B C-terminal in the BLA, which interferes with the C-terminal mediated intracellular signaling, produced a severe deficit in auditory fear memory for five but not one CS-US pairing protocol, whereas over-expression of NR2A C-terminal produced a deficient memory for both protocols. There seems a recruitment mechanism in the hippocampus and amygdala for involvement of NR2B-NMDARs in memory acquisition: the heavier the training load is, the more involved the NR2B-NMDAR is.

Selectivity of NVP-AAM077

NR2A- and NR2B-NMDARs have distinct electrophysiological and signaling properties [8, 27, 42–48]. Dissection of the functions of NR2A- and NR2B-NMDARs will promote our understanding of their roles in learning and memory. As specific antagonists for NR2A-NMDAR are not available, the role of NR2A-NMDARs in learning and memory is still poorly understood. Recently, a relatively selective NR2A-NMDAR antagonist, NVP-AAM077, has been developed. However, some previous studies argue that NVP-AAM077 is not sufficient to discriminate between NR2A- and NR2B-NMDARs, with about 10-fold higher selectivity for NR2A- than for NR2B-NMDARs [49, 50].

In the present study, we used NVP-AAM077 (0.012 or 0.12 μg in 1.0 μl vehicle) for pharmacological blockade of NR2A-NMDARs in the CA1 region. We found that treatment with NVP-AAM077 non-differentially impaired the acquisition of fear memory induced by the two conditioning protocols, one of which included a single CS-US pairing and the other five CS-US pairings. Although NVP-AAM077 could act at NR2B as well, it is unlikely that the NVP-AAM077 effect was mediated by NR2B-NMDARs, because similar treatment with the selective NR2B-NMDAR antagonist ifenprodil (0.2 μg in 1.0 μl vehicle, equal molarity with 0.12 μg/1.0 μl NVP-AAM077) or Ro25-6981 (5.0 μg) impaired the acquisition of fear memory induced by the single CS-US pairing protocol. This result strongly suggests an essential role of NR2A-NMDARs in the CA1 region in acquisition of contextual fear memory, regardless of conditioning strength.

In summary, the present study strongly suggests an induction- and conditioning-protocol dependent involvement of NR2B-NMDARs in the CA1 region in long-term potentiation and contextual fear memory formation.

Declarations

Acknowledgements

This work was supported by grants to BML from the Ministry of Science and Technology of China (2006CB500807 and 2006AA02Z199), the Ministry of Education of China (Program for Changjiang Scholars and Innovative Research Team in University), and the National Natural Science Foundation of China (NSFC) (30225023 and 30430240), and to XHZ from the NSFC (30700218).

This work was also supported by grants to MZ from the Canadian Institutes of Health Research, the EJLB-CIHR Michael Smith Chair in Neurosciences and Mental Health, the Canada Research Chair, and the NSFC (30528010), and the China-Canada Joint Health Research Initiative (NSFC grant 30611120530 to BML and MZ).

Authors’ Affiliations

(1)
Institute of Neurobiology and State Key Laboratory of Medical Neurobiology, Institutes of Brain Science, Fudan University, Shanghai, China
(2)
Department of Physiology, Faculty of Medicine, University of Toronto, Toronto, Canada

References

  1. Bliss TV, Collingridge GL: A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 1993, 361 (6407): 31-39. 10.1038/361031a0.View ArticlePubMedGoogle Scholar
  2. Malenka RC, Nicoll RA: NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci. 1993, 16 (12): 521-527. 10.1016/0166-2236(93)90197-T.View ArticlePubMedGoogle Scholar
  3. Tsien JZ, Huerta PT, Tonegawa S: The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 1996, 87 (7): 1327-1338. 10.1016/S0092-8674(00)81827-9.View ArticlePubMedGoogle Scholar
  4. Cull-Candy S, Brickley S, Farrant M: NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol. 2001, 11 (3): 327-335. 10.1016/S0959-4388(00)00215-4.View ArticlePubMedGoogle Scholar
  5. Dingledine R, Borges K, Bowie D, Traynelis SF: The glutamate receptor ion channels. Pharmacol Rev. 1999, 51 (1): 7-61.PubMedGoogle Scholar
  6. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K, Meguro H, Masaki H, Kumanishi T, Arakawa M, Mishina M: Molecular diversity of the NMDA receptor channel. Nature. 1992, 358 (6381): 36-41. 10.1038/358036a0.View ArticlePubMedGoogle Scholar
  7. Loftis JM, Janowsky A: The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol Ther. 2003, 97 (1): 55-85. 10.1016/S0163-7258(02)00302-9.View ArticlePubMedGoogle Scholar
  8. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH: Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science. 1992, 256 (5060): 1217-1221. 10.1126/science.256.5060.1217.View ArticlePubMedGoogle Scholar
  9. Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT: Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science. 2004, 304 (5673): 1021-1024. 10.1126/science.1096615.View ArticlePubMedGoogle Scholar
  10. Massey PV, Johnson BE, Moult PR, Auberson YP, Brown MW, Molnar E, Collingridge GL, Bashir ZI: Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J Neurosci. 2004, 24 (36): 7821-7828. 10.1523/JNEUROSCI.1697-04.2004.View ArticlePubMedGoogle Scholar
  11. Malenka RC, Nicoll RA: Long-term potentiation – a decade of progress?. Science. 1999, 285 (5435): 1870-1874. 10.1126/science.285.5435.1870.View ArticlePubMedGoogle Scholar
  12. Weitlauf C, Honse Y, Auberson YP, Mishina M, Lovinger DM, Winder DG: Activation of NR2A-containing NMDA receptors is not obligatory for NMDA receptor-dependent long-term potentiation. J Neurosci. 2005, 25 (37): 8386-8390. 10.1523/JNEUROSCI.2388-05.2005.View ArticlePubMedGoogle Scholar
  13. Berberich S, Punnakkal P, Jensen V, Pawlak V, Seeburg PH, Hvalby O, Kohr G: Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J Neurosci. 2005, 25 (29): 6907-6910. 10.1523/JNEUROSCI.1905-05.2005.View ArticlePubMedGoogle Scholar
  14. Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ: Genetic enhancement of learning and memory in mice. Nature. 1999, 401 (6748): 63-69. 10.1038/43432.View ArticlePubMedGoogle Scholar
  15. Ji J, Maren S: Differential roles for hippocampal areas CA1 and CA3 in the contextual encoding and retrieval of extinguished fear. Learn Mem. 2008, 15 (4): 244-251. 10.1101/lm.794808.PubMed CentralView ArticlePubMedGoogle Scholar
  16. Daumas S, Halley H, Frances B, Lassalle JM: Encoding, consolidation, and retrieval of contextual memory: differential involvement of dorsal CA3 and CA1 hippocampal subregions. Learn Mem. 2005, 12 (4): 375-382. 10.1101/lm.81905.PubMed CentralView ArticlePubMedGoogle Scholar
  17. Fanselow MS, Kim JJ, Yipp J, De Oca B: Differential effects of the N-methyl-D-aspartate antagonist DL-2-amino-5-phosphonovalerate on acquisition of fear of auditory and contextual cues. Behav Neurosci. 1994, 108 (2): 235-240. 10.1037/0735-7044.108.2.235.View ArticlePubMedGoogle Scholar
  18. Bast T, Zhang WN, Feldon J: Dorsal hippocampus and classical fear conditioning to tone and context in rats: effects of local NMDA-receptor blockade and stimulation. Hippocampus. 2003, 13 (6): 657-675. 10.1002/hipo.10115.View ArticlePubMedGoogle Scholar
  19. Melik E, Babar E, Ozen E, Ozgunen T: Hypofunction of the dorsal hippocampal NMDA receptors impairs retrieval of memory to partially presented foreground context in a single-trial fear conditioning in rats. Eur Neuropsychopharmacol. 2006, 16 (4): 241-247. 10.1016/j.euroneuro.2005.07.008.View ArticlePubMedGoogle Scholar
  20. Bi GQ, Poo MM: Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. J Neurosci. 1998, 18 (24): 10464-10472.PubMedGoogle Scholar
  21. Markram H, Lubke J, Frotscher M, Sakmann B: Regulation of synaptic efficacy by coincidence of postsynaptic APs and EPSPs. Science. 1997, 275 (5297): 213-215. 10.1126/science.275.5297.213.View ArticlePubMedGoogle Scholar
  22. Wu LJ, Xu H, Ren M, Cao XY, Zhuo M: Parmacological Isolation of Postsynaptic Currents Mediated by NR2A- and NR2B-containing NMDA Receptors in the Anterior Cingulate Cortex. Molecular Pain. 2007Google Scholar
  23. Rodrigues SM, Schafe GE, LeDoux JE: Intra-amygdala blockade of the NR2B subunit of the NMDA receptor disrupts the acquisition but not the expression of fear conditioning. J Neurosci. 2001, 21 (17): 6889-6896.PubMedGoogle Scholar
  24. Zhao MG, Toyoda H, Lee YS, Wu LJ, Ko SW, Zhang XH, Jia Y, Shum F, Xu H, Li BM, Kaang BK, Zhuo M: Roles of NMDA NR2B subtype receptor in prefrontal long-term potentiation and contextual fear memory. Neuron. 2005, 47 (6): 859-872. 10.1016/j.neuron.2005.08.014.View ArticlePubMedGoogle Scholar
  25. Nakazawa T, Komai S, Watabe AM, Kiyama Y, Fukaya M, Arima-Yoshida F, Horai R, Sudo K, Ebine K, Delawary M, Goto J, Umemori H, Tezuka T, Iwakura Y, Watanabe M, Yamamoto T, Manabe T: NR2B tyrosine phosphorylation modulates fear learning as well as amygdaloid synaptic plasticity. Embo J. 2006, 25 (12): 2867-2877. 10.1038/sj.emboj.7601156.PubMed CentralView ArticlePubMedGoogle Scholar
  26. Kohr G, Jensen V, Koester HJ, Mihaljevic AL, Utvik JK, Kvello A, Ottersen OP, Seeburg PH, Sprengel R, Hvalby O: Intracellular domains of NMDA receptor subtypes are determinants for long-term potentiation induction. J Neurosci. 2003, 23 (34): 10791-10799.PubMedGoogle Scholar
  27. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH: Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron. 1994, 12 (3): 529-540. 10.1016/0896-6273(94)90210-0.View ArticlePubMedGoogle Scholar
  28. Barth AL, Malenka RC: NMDAR EPSC kinetics do not regulate the critical period for LTP at thalamocortical synapses. Nat Neurosci. 2001, 4 (3): 235-236. 10.1038/85070.View ArticlePubMedGoogle Scholar
  29. Sprengel R, Suchanek B, Amico C, Brusa R, Burnashev N, Rozov A, Hvalby O, Jensen V, Paulsen O, Andersen P, Kim JJ, Thompson RF, Sun W, Webster LC, Grant SG, Eilers J, Konnerth A, Li J, McNamara JO, Seeburg PH: Importance of the intracellular domain of NR2 subunits for NMDA receptor function in vivo. Cell. 1998, 92 (2): 279-289. 10.1016/S0092-8674(00)80921-6.View ArticlePubMedGoogle Scholar
  30. Bauer EP, Schafe GE, LeDoux JE: NMDA receptors and L-type voltage-gated calcium channels contribute to long-term potentiation and different components of fear memory formation in the lateral amygdala. J Neurosci. 2002, 22 (12): 5239-5249.PubMedGoogle Scholar
  31. Berberich SJV, Hvalby O, Seeburg PH, Kohr G: The role of NMDAR subtypes and charge transfer during hippocampal LTP induction. Neuropharmacology. 2007, 52 (1): 77-86. 10.1016/j.neuropharm.2006.07.016.View ArticlePubMedGoogle Scholar
  32. Hoffman DA, Sprengel R, Sakmann B: Molecular dissection of hippocampal theta-burst pairing potentiation. Proc Natl Acad Sci USA. 2002, 99 (11): 7740-7745. 10.1073/pnas.092157999.PubMed CentralView ArticlePubMedGoogle Scholar
  33. Lisman J: Long-term potentiation: outstanding questions and attempted synthesis. Philos Trans R Soc Lond B Biol Sci. 2003, 358 (1432): 829-842. 10.1098/rstb.2002.1242.PubMed CentralView ArticlePubMedGoogle Scholar
  34. Minichiello L, Calella AM, Medina DL, Bonhoeffer T, Klein R, Korte M: Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron. 2002, 36 (1): 121-137. 10.1016/S0896-6273(02)00942-X.View ArticlePubMedGoogle Scholar
  35. Madison DV, Malenka RC, Nicoll RA: Mechanisms underlying long-term potentiation of synaptic transmission. Annu Rev Neurosci. 1991, 14: 379-397. 10.1146/annurev.ne.14.030191.002115.View ArticlePubMedGoogle Scholar
  36. Lisman J, Schulman H, Cline H: The molecular basis of CaMKII function in synaptic and behavioural memory. Nat Rev Neurosci. 2002, 3 (3): 175-190. 10.1038/nrn753.View ArticlePubMedGoogle Scholar
  37. Gerkin RC, Lau PM, Nauen DW, Wang YT, Bi GQ: Modular competition driven by NMDA receptor subtypes in spike-timing-dependent plasticity. J Neurophysiol. 2007, 97 (4): 2851-2862. 10.1152/jn.00860.2006.View ArticlePubMedGoogle Scholar
  38. Zhou YD, Acker CD, Netoff TI, Sen K, White JA: Increasing Ca2+ transients by broadening postsynaptic action potentials enhances timing-dependent synaptic depression. Proc Natl Acad Sci USA. 2005, 102 (52): 19121-19125. 10.1073/pnas.0509856103.PubMed CentralView ArticlePubMedGoogle Scholar
  39. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M: Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci. 2001, 4 (2): 164-169. 10.1038/83993.View ArticlePubMedGoogle Scholar
  40. Wu LJ, Toyoda H, Zhao MG, Lee YS, Tang J, Ko SW, Jia YH, Shum FW, Zerbinatti CV, Bu G, Wei F, Xu TL, Muglia LJ, Chen ZF, Auberson YP, Kaang BK, Zhuo M: Upregulation of forebrain NMDA NR2B receptors contributes to behavioral sensitization after inflammation. J Neurosci. 2005, 25 (48): 11107-11116. 10.1523/JNEUROSCI.1678-05.2005.View ArticlePubMedGoogle Scholar
  41. Zhang XH, Liu F, Chen Q, Zhang CL, Zhuo M, Xiong ZQ, Li BM: Conditioning-strength dependent involvement of NMDA NR2B subtype receptor in the basolateral nucleus of amygdala in acquisition of auditory fear memory. Neuropharmacology. 2008Google Scholar
  42. Priestley T, Laughton P, Myers J, Le Bourdelles B, Kerby J, Whiting PJ: Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol Pharmacol. 1995, 48 (5): 841-848.PubMedGoogle Scholar
  43. Carmignoto G, Vicini S: Activity-dependent decrease in NMDA receptor responses during development of the visual cortex. Science. 1992, 258 (5084): 1007-1011. 10.1126/science.1279803.View ArticlePubMedGoogle Scholar
  44. Sans N, Petralia RS, Wang YX, Blahos J, Hell JW, Wenthold RJ: A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci. 2000, 20 (3): 1260-1271.PubMedGoogle Scholar
  45. Barria A, Malinow R: NMDA receptor subunit composition controls synaptic plasticity by regulating binding to CaMKII. Neuron. 2005, 48 (2): 289-301. 10.1016/j.neuron.2005.08.034.View ArticlePubMedGoogle Scholar
  46. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG: Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci. 2000, 3 (7): 661-669. 10.1038/76615.View ArticlePubMedGoogle Scholar
  47. Steigerwald F, Schulz TW, Schenker LT, Kennedy MB, Seeburg PH, Kohr G: C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors. J Neurosci. 2000, 20 (12): 4573-4581.PubMedGoogle Scholar
  48. Vissel B, Krupp JJ, Heinemann SF, Westbrook GL: Intracellular domains of NR2 alter calcium-dependent inactivation of N-methyl-D-aspartate receptors. Mol Pharmacol. 2002, 61 (3): 595-605. 10.1124/mol.61.3.595.View ArticlePubMedGoogle Scholar
  49. Frizelle PA, Chen PE, Wyllie DJ: Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquino xalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission. Mol Pharmacol. 2006, 70 (3): 1022-1032. 10.1124/mol.106.024042.View ArticlePubMedGoogle Scholar
  50. Paoletti P, Neyton J: NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol. 2007, 7 (1): 39-47. 10.1016/j.coph.2006.08.011.View ArticlePubMedGoogle Scholar

Copyright

© Zhang et al; licensee BioMed Central Ltd. 2008

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Advertisement

Molecular Brain

ISSN: 1756-6606